1. Statistics Korea [Internet]. 2012. cited 2013 Jan 4. Daejeon: Statistics Korea;Available from:
http://kostat.go.kr
.
2. Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, et al. Measuring the burden of disease in Korea. J Korean Med Sci. 2007; 22:518–523. PMID:
17596664.
Article
3. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44:11–24. PMID:
22500156.
Article
4. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009; 41:122–131. PMID:
19809561.
Article
5. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–331. PMID:
19956367.
Article
6. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998; 45:1011–1017. PMID:
9893469.
7. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 2000. 3rd ed. Geneva: World Health Organization.
8. World Health Organization. International statistical classification of diseases and related health problems. 1994. 10th rev. Geneva: World Health Organization.
9. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). 1960. Sendai: Tohoku University School of Medicine.
10. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007. 2010. Bethesda, MD: National Cancer Institute.
11. National Cancer Institute. SEER*Stat Program, version 6.6.1 [Internet]. cited 2013 Jan 4. Bethesda, MD: U. S. National Cancer Institute;Available from:
http://seer.cancer.gov/seerstat/2010
.
12. Ederer F, Heise H. Instructions to IBM programmers in processing survival computations. Methodological note No. 10. 1959. Bethesda, MD: National Cancer Institute.
14. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295:2164–2167. PMID:
16684987.
Article
15. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009; 18:784–791. PMID:
19240234.
Article
16. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev. 2011; 12:1657–1663. PMID:
22126540.
17. Kim SY. Study to provide evidence of health screening service for thyroid cancer. 2012. cited 2013 Jan 4. Seoul: National Evidence based Healthcare Collaborating Agency;Available from:
http://www.neca.re.kr/
.
18. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents. 2007. Vol. 9. Lyon: IARC Press.
19. Jung KW, Yim SH, Kong HJ, Hwang SY, Won YJ, Lee JK, et al. Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci. 2007; 22(Suppl):S5–S10. PMID:
17923755.
Article
20. Gondos A, Bray F, Hakulinen T, Brenner H. EUNICE Survival Working Group. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol. 2009; 20:564–573. PMID:
19066327.
Article
21. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006; 260:103–117. PMID:
16882274.
Article